Literature DB >> 7507069

[Palliative treatment by endoprosthesis of icterus caused by distal biliary tumoral obstruction].

C Buffet1, T Couderc, J Fritsch, A Choury, J F Lefebvre, V Marteau, O Ink, D Bonnel, C Liguory, J P Etienne.   

Abstract

Between March 1982 and December 1987, 466 patients (256 women, 210 men, mean age 73 years) with tumor obstruction of the common bile duct were referred to our department. The causes of obstruction were carcinoma of the pancreas (298 patients), carcinoma of the ampulla of Vater (32 patients) and carcinoma of the common bile duct (136 patients). Endoscopical insertion of a biliary prosthesis was initially possible in 377 patients (81%). In case of failure, patients were referred to the radiologist for percutaneous drainage. Successful drainage was obtained in 58 patients with an overall success rate of 93% (435 patients). Endoscopic replacement was necessary in 170 cases for 114 patients and was successful in 155 (91%). Pruritus was relieved in 89% of the patients. Serum bilirubin levels decreased more than 75% after initial endoscopic endoprosthesis, repeated endoscopic endoprosthesis and percutaneous prosthesis insertion in 80%, 79%, and 62% of the patients, respectively. Short term complications of endoscopic endoprosthesis occurred in 28% of patients with a mortality rate of 8%. Percutaneous prosthesis complications occurred in 33% of patients with a mortality rate of 11%. In the long term, cholangitis was the main complication and occurred in 27% of patients with a delay of 103 +/- 105 days. Intestinal obstruction was observed in 7% of patients. The average life expectancy of endoscopic endoprosthesis and percutaneous prosthesis was 109 +/- 157 and 92 +/- 101 days, respectively. The average life expectancy of patients was 163 +/- 224 days.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 7507069

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  5 in total

1.  Endoscopic management of occluded metal biliary stents: metal versus 10F plastic stents.

Authors:  Won Jae Yoon; Ji Kon Ryu; Jung Won Lee; Dong-Won Ahn; Yong-Tae Kim; Yong Bum Yoon; Sang Myung Woo; Woo Jin Lee
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Treatment of malignant digestive tract obstruction by combined intraluminal stent installation and intra-arterial drug infusion.

Authors:  A W Mao; Z D Gao; J Y Xu; R J Yang; X S Xiao; T H Jiang; W J Jiang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline.

Authors:  F Prat; O Chapat; B Ducot; T Ponchon; J Fritsch; A D Choury; G Pelletier; C Buffet
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

4.  The underutilization of EUS-guided biliary drainage: Perception of endoscopists in the East and West.

Authors:  Won Jae Yoon; Do Hyun Park; Jun Ho Choi; Sunguk Jang; Jason Samarasena; Tae Hoon Lee; Woo Hyun Paik; Dongwook Oh; Tae Jun Song; Joon Hyuk Choi; Kazuo Hara; Takuji Iwashita; Manuel Perez-Miranda; John G Lee; Enrique Vazquez-Sequeiros; Itaru Naitoh; Juan J Vila; William R Brugge; Mamoru Takenaka; Sang Soo Lee; Dong-Wan Seo; Sung Koo Lee; Myung-Hwan Kim
Journal:  Endosc Ultrasound       Date:  2019 May-Jun       Impact factor: 5.628

5.  Endoscopic Ultrasound-Guided Versus Percutaneous Transhepatic Biliary Drainage in Patients With Malignant Biliary Obstruction: Which Is the Optimal Cost-Saving Strategy After Failed ERCP?

Authors:  Won Jae Yoon; Eric D Shah; Tae Hoon Lee; Sunguk Jang; Ryan Law; Do Hyun Park
Journal:  Front Oncol       Date:  2022-02-25       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.